Abstract
HbA1c gives an integrated index of glycemia over the entire 120 days lifespan of red blood cells. Therefore, measuring HbA1c would be appropriate in diagnosing adisease characterized by chronic hyperglycemia and a gradual progression to complications.Objectives: our primary objective was to evaluate the use of HbA1c as screening test forundiagnosed diabetes (WHO criteria of Fasting plasma glucose (FPG) of ≥ 7mmol/l (126mg/dl))in healthy asymptomatic individuals in Pakistani population. Study Design and Methodology:A cross sectional population survey was carried on asymptomatic, healthy individuals withoutpast history of diabetes. Venous blood was obtained to measure fasting plasma glucose(fasting > 8 hours) and Hb A1c. Place and Duration of Study: Khan lab Sargodha from July2013 to March 2014. The test: It was performed by using NycoCard HbA1c in vitro diagnosticmedical device for quantitative determination of glycated hemoglobin in whole blood. Results:In our sample size of 775, the lowest HbA1c was found to be 5% and Highest 13.2%. Arithmeticmeans was 6.7565%, while the median value was 6.2% and standard deviation 1.3323. Whenusing FPG only, the detection rate of diabetes was 32.65% (female, 14.71%; male, 17.94%).When HbA1c was included as a diagnostic test, the detection rate increased to 40% (female,18.84%; male, 21.16 %). An additional 7.6% of participants were diagnosed with diabetes whenusing HbA1c criteria. ROC (A receiver operating characteristic) curve was used for analysis.At HbA1c cutoff of ≥6.5% it demonstrated sensitivity of 98.02% (95% CI) and specificity of88.12% (95% CI) for detection of undiagnosed diabetes mellitus in healthy asymptomaticindividuals in Pakistani population. Area under the ROC curve was 0.981354 with significancelevel P (Area=0.5) 0.0001. Conclusions: Our study reveals that HbA1c is a highly specific andconvenient alternative to fasting plasma glucose for screening of diabetes mellitus in Pakistanipopulation. A large scale survey should be carried out to set our own national standardizations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.